Akums Drugs and Pharmaceuticals has secured European GMP certifications for its Plant 1 and Plant 2 manufacturing facilities located in Haridwar, Uttarakhand. While Plant 1’s certification is a renewal, Plant 2 has received this certification for the first time. These certifications will enable Akums to access EU-regulated markets and pursue new business opportunities within the European Union and other regions that adhere to EU-GMP standards.
European GMP Certification
Akums Drugs and Pharmaceuticals Ltd. has been granted European Good Manufacturing Practice (GMP) certifications for two of its key manufacturing plants. These facilities, Plant 1 and Plant 2, are both situated in Haridwar, Uttarakhand.
Plant-Specific Details
The certification for Plant 1 represents a renewal of its existing EU-GMP approval, ensuring continued compliance with stringent European standards. Plant 2, on the other hand, has newly received EU-GMP certification, marking a significant milestone for the company.
Impact on Market Access
These certifications will empower Akums to effectively serve EU-regulated markets, expanding its reach and scope in the pharmaceutical sector. The company also aims to explore new business prospects within the EU and other markets that follow EU-GMP guidelines. The European CDMO contract signed in December 2024 will be serviced from Plant 2.
Manufacturing Capabilities
With these approvals, Plant 1 is authorized to manufacture and supply tablets, hard gelatine capsules, and sachet dosage forms for EU countries. Plant 2 is authorized to manufacture and supply oral liquid formulations for EU countries.
Source: BSE
